Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017156103) NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/156103 International Application No.: PCT/US2017/021325
Publication Date: 14.09.2017 International Filing Date: 08.03.2017
IPC:
A61K 31/57 (2006.01) ,A61K 31/56 (2006.01) ,A61K 31/575 (2006.01) ,A61K 31/58 (2006.01)
[IPC code unknown for A61K 31/57][IPC code unknown for A61K 31/56][IPC code unknown for A61K 31/575][IPC code unknown for A61K 31/58]
Applicants:
SAGE THERAPEUTICS, INC. [US/US]; 215 First Street Cambridge, MA 02142, US
Inventors:
KANES, Stephen, Jay; US
COLQUHOUN, Helen; US
Agent:
MCCARTY, Catherine, M.; US
Priority Data:
62/305,27908.03.2016US
62/355,17427.06.2016US
62/355,66928.06.2016US
62/360,75811.07.2016US
62/360,76211.07.2016US
Title (EN) NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
(FR) STÉROÏDES NEUROACTIFS, COMPOSITIONS, ET LEURS UTILISATIONS
Abstract:
(EN) Described herein are methods of treating a disorder, e.g., tremor, e.g., essential tremor; depression, e.g., postpostum depression; and anxiety disorder, the method comprising administering to a human subject suffering from a disorder, e.g., tremor, e.g., essential tremor; depression, e.g., postpostum depression, an anxiety disorder with a neuroactive steroid or a composition comprising a neuroactive steroid (e.g., pregnanolone, allopregnanolone, alphadalone, ganaxolone, or alphaxolone).
(FR) La présente invention concerne des procédés de traitement d'un trouble, par exemple de tremblement, par exemple de tremblement essentiel ; de dépression, par exemple de dépression post-partum ; et du trouble anxieux, le procédé consistant à administrer à un sujet humain souffrant d'un trouble, par exemple de tremblement, par exemple de tremblement essentiel ; de dépression, par exemple de dépression post-partum, ou d'un trouble anxieux, un stéroïde neuroactif ou une composition comprenant un stéroïde neuroactif (par exemple, pregnanolone, allopregnanolone, alphadalone, ganaxolone ou alphaxolone).
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)